Ligand Pharmaceuticals, Inc. (LGND)
275.20
-1.78
(-0.64%)
USD |
NASDAQ |
Sep 16, 16:00
274.95
-0.25
(-0.09%)
After-Hours: 05:06
Ligand Pharmaceuticals Total Return Level : 366.21 for Sept. 16, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 16, 2026 | 366.21 |
| September 15, 2026 | 368.57 |
| September 14, 2026 | 373.46 |
| September 11, 2026 | 378.54 |
| September 10, 2026 | 384.90 |
| September 09, 2026 | 383.30 |
| September 08, 2026 | 384.34 |
| September 04, 2026 | 380.04 |
| September 03, 2026 | 385.55 |
| September 02, 2026 | 381.80 |
| September 01, 2026 | 378.27 |
| August 31, 2026 | 378.05 |
| August 28, 2026 | 373.24 |
| August 27, 2026 | 378.61 |
| August 26, 2026 | 383.04 |
| August 25, 2026 | 374.88 |
| August 24, 2026 | 372.83 |
| August 21, 2026 | 380.96 |
| August 20, 2026 | 382.43 |
| August 19, 2026 | 386.84 |
| August 18, 2026 | 382.69 |
| August 17, 2026 | 388.25 |
| August 14, 2026 | 392.01 |
| August 13, 2026 | 384.33 |
| August 12, 2026 | 390.25 |
| Date | Value |
|---|---|
| August 11, 2026 | 384.24 |
| August 10, 2026 | 393.48 |
| August 07, 2026 | 390.09 |
| August 06, 2026 | 399.39 |
| August 05, 2026 | 402.63 |
| August 04, 2026 | 400.26 |
| August 03, 2026 | 388.61 |
| July 31, 2026 | 382.63 |
| July 30, 2026 | 394.27 |
| July 29, 2026 | 383.25 |
| July 28, 2026 | 394.26 |
| July 27, 2026 | 395.88 |
| July 24, 2026 | 399.91 |
| July 23, 2026 | 402.07 |
| July 22, 2026 | 404.88 |
| July 21, 2026 | 406.49 |
| July 20, 2026 | 391.21 |
| July 17, 2026 | 403.72 |
| July 16, 2026 | 394.48 |
| July 15, 2026 | 394.23 |
| July 14, 2026 | 400.50 |
| July 13, 2026 | 411.52 |
| July 10, 2026 | 420.82 |
| July 09, 2026 | 429.29 |
| July 08, 2026 | 419.01 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Johnson & Johnson | 637.79 |
| Eli Lilly & Co. | 3006.36 |
| Merck & Co., Inc. | 448.12 |
| Zevra Therapeutics, Inc. | 11.80 |
| Liquidia Corp. | 68.45 |